WHO ICTRP trial
A phase II multicentric study in adults with acute myelogenous leukaemia (AML)…
EUCTR2009-016601-42-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-016601-42-FR |
|---|---|
| Public title | A phase II multicentric study in adults with acute myelogenous leukaemia (AML) in first complete remission (CR1) using IV BuCy2 in a once daily Bu regimen targeting a narrow therapeutic window prior to hematopoietic stem cell transplantation. |
| Scientific title | A phase II multicentric study in adults with acute myelogenous leukaemia (AML) in first complete remission (CR1) using IV BuCy2 in a once daily Bu regimen targeting a narrow therapeutic window prior to hematopoietic stem cell transplantation. |
| Primary sponsor | PIERRE FABRE MEDICAMENT |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France;Spain;Italy |
| Conditions | Acute myeloid leukaemia MedDRA version: 12.1 Level: PT Classification code 10000881 Term: |
| Interventions | Trade Name: BUSILVEX Product Name: BUSILVEX Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Busulfan Current Sponsor code: F60002 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal… |
| Registration date | Apr 1, 2010 |
| Target size | 28 |
| Secondary IDs | F60002 IN 202 G0 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: